Clinical studies recruiting near Canton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230 Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Alexion Pharmaceuticals, Inc. · NCT07157787 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Pfizer · NCT05020236 Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
Phase 2 · Sun Yat-sen University · NCT05011487 Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 cfMSC Therapy for Diabetes
Phase 1/Phase 2 · Shenzhen Geno-Immune Medical Institute · NCT07495956 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Phase 1 · Second Affiliated Hospital of Guangzhou Medical University · NCT04952272 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · Colorado Prevention Center · NCT06024746 ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Phase 1/Phase 2 · Sun Yat-sen University · NCT07012954 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Sanofi · NCT06867094 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853 Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Phase N/A · Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856 Electro-Acupuncture in Lung cancER : EALER Study
NA · Guangzhou University of Traditional Chinese Medicine · NCT07337096 NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Phase 1 · Shenzhen Geno-Immune Medical Institute · NCT05262673 H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
Phase 1/Phase 2 · Shenzhen Geno-Immune Medical Institute · NCT07501156 A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · AstraZeneca · NCT07404202 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559 IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 · Sun Yat-sen University · NCT05941741 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Phase 3 · Sun Yat-sen University · NCT04136886 Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NA · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07126470 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Huabo Biopharm Co., Ltd. · NCT06592274 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Cleveland Clinic - Mercy Hospital ( Site 0057) · Merck Sharp & Dohme LLC · NCT06393374 Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in
Phase 4 · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06520397 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Illinois CancerCare-Canton · National Cancer Institute (NCI) · NCT05564390 Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Phase 2 · Sun Yat-sen University · NCT07389629 Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI
NA · Nanfang Hospital, Southern Medical University · NCT05545605

Look up another city

Look up another condition